Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients

Clinical Interventions in Aging

Volumn 7, Issue , 2012, Pages 489-497

  Godard, Michael P ^a   Whitman, Samantha A ^b   Song, Yao Hua ^c   Delafontaine, Patrice ^d  

^a UNIVERSITY OF CENTRAL MISSOURI   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c SOOCHOW UNIVERSITY   (China)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hybrid fibers; IGF1 and IGFBP 5; Muscle quality

Indexed keywords

MYOSIN HEAVY CHAIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IGF 1 GENE; IGFBP 5 GENE; ISOMETRICS; MOLECULAR BIOLOGY; MUSCLE CELL; MUSCLE ISOMETRIC CONTRACTION; MUSCLE QUALITY; MUSCLE SIZE; MUSCLE STRENGTH; MYOPATHY; PHYSICAL ACTIVITY; PROTEIN EXPRESSION;

AGED; BIOPSY, NEEDLE; EXERCISE; FEMALE; HEART; HEART FAILURE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; RNA, MESSENGER;

EID: 84872294512     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S37879     Document Type: Article

References (45)

1. American Heart Association. Heart Disease and Stroke Statistics: 2007 Update At-a-Glance. Dallas: American Heart Association; 2007. Available from: http://www.harcdata.org/UserFiles/File/AHA-heartandstrokestats.pdf. Accessed October 10, 2012.
2. Sigurdsson A, Amtorp O, Gundersen T, Nilsson B, Remes J, Swedberg K. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group. Br Heart J. 1994;72(5):422-427.
3. Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest. 2005;115(2):451-458.
4. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16(1):3-34.
5. Butt AJ, Firth SM, Baxter RC. The IGF axis and programmed cell death. Immunol Cell Biol. 1999;77(3):256-262.
6. Resnicoff M, Baserga R. The role of the insulin-like growth factor I receptor in transformation and apoptosis. Ann N Y Acad Sci. 1998;842: 76-81.
7. Musarò A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature. 1999;400(6744): 581-585.
8. DeVol DL, Rotwein P, Sadow JL, Novakofski J, Bechtel PJ. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol. 1990;259(1 Pt 1):E89-E95.
9. Léger B, Derave W, De Bock K, Hespel P, Russell AP. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res. 2008;11(1):163B-175B.
10. Serose A, Prudhon B, Salmon A, Doyennette MA, Fiszman MY, Fromes Y. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster. Basic Res Cardiol. 2005;100(2):161-170.
11. Kopple JD, Cohen AH, Wang H, etal. Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients. J Ren Nutr. 2006;16(4):312-324.
12. Drexler H. Effect of angiotensin-converting enzyme inhibitors on the peripheral circulation in heart failure. Am J Cardiol. 1992;70(10):50C-54C.
13. Mancini DM, Coyle E, Coggan A, etal. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation. 1989;80(5):1338-1346.
14. Mancini DM, Walter G, Reichek N, etal. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85(4):1364-1373.
15. Schaufelberger M, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J. 1997;18(6):971-980.
16. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80(4):769-781.
17. Delp MD, Duan C, Mattson JP, Musch TI. Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure. J Appl Physiol. 1997;83(4):1291-1299.
18. Lang CC, Chomsky DB, Rayos G, Yeoh TK, Wilson JR. Skeletal muscle mass and exercise performance in stable ambulatory patients with heart failure. J Appl Physiol. 1997;82(1):257-261.
19. Sullivan MJ, Duscha BD, Klitgaard H, Kraus WE, Cobb FR, Saltin B. Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc. 1997;29(7):860-866.
20. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990;81(2):518-527.
21. Toth MJ, Matthews DE, Ades PA, etal. Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am J Physiol Endocrinol Metab. 2005;288(4): E685-E692.
22. Vescovo G, Serafini F, Facchin L, etal. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart. 1996;76(4):337-343.
23. Short KR, Vittone JL, Bigelow ML, etal. Changes in myosin heavy chain mRNA and protein expression in human skeletal muscle with age and endurance exercise training. J Appl Physiol. 2005;99(1):95-102.
24. Andersen JL. Muscle fibre type adaptation in the elderly human muscle. Scand J Med Sci Sports. 2003;13(1):40-47.
25. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation. 1991;84(4):1597-1607.
26. Toth MJ, Ades PA, Lewinter MM, Tracy RP, Tchernof A. Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J Appl Physiol. 2006;100(1):35-41.
27. Dipietro L, Caspersen CJ, Ostfeld AM, Nadel ER. A survey for assessing physical activity among older adults. Med Sci Sports Exerc. 1993;25(5): 628-642.
28. Williamson DL, Godard MP, Porter DA, Costill DL, Trappe SW. Progressive resistance training reduces myosin heavy chain coexpression in single muscle fibers from older men. J Appl Physiol. 2000;88(2): 627-633.
29. Trappe S, Gallagher P, Harber M, Carrithers J, Fluckey J, Trappe T. Single muscle fibre contractile properties in young and old men and women. J Physiol. 2003;552(Pt 1):47-58.
30. Coirault C, Guellich A, Barbry T, Samuel JL, Riou B, Lecarpentier Y. Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure. Am J Physiol Heart Circ Physiol. 2007;292(2):H1009-H1017.
31. Duscha BD, Kraus WE, Keteyian SJ, etal. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in Class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol. 1999;33(7):1956-1963.
32. Toth MJ, Palmer BM, LeWinter MM. Effect of heart failure on skeletal muscle myofibrillar protein content, isoform expression and calcium sensitivity. Int J Cardiol. 2006;107(2):211-219.
33. Tracy BL, Ivey FM, Hurlbut D, etal. Muscle quality. II. Effects of strength training in 65-to 75-yr-old men and women. J Appl Physiol. 1999;86(1):195-201.
34. Godard MP, Gallagher PM, Raue U, Trappe SW. Alterations in single muscle fiber calcium sensitivity with resistance training in older women. Pflugers Arch. 2002;444(3):419-425.
35. Trappe S. Effects of spaceflight, simulated spaceflight and countermeasures on single muscle fiber physiology. J Gravit Physiol. 2002;9(1):P323-P326.
36. Trappe S, Harber M, Creer A, etal. Single muscle fiber adaptations with marathon training. J Appl Physiol. 2006;101(3):721-727.
37. Trappe S, Trappe T, Gallagher P, Harber M, Alkner B, Tesch P. Human single muscle fibre function with 84day bed-rest and resistance exercise. J Physiol. 2004;557(Pt 2):501-513.
38. Talmadge RJ. Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerve. 2000;23(5):661-679.
39. Talmadge RJ, Roy RR, Edgerton VR. Persistence of hybrid fibers in rat soleus after spinal cord transection. Anat Rec. 1999;255(2):188-201.
40. Hambrecht R, Schulze PC, Gielen S, etal. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2002;39(7): 1175-1181.
41. Adams V, Nehrhoff B, Späte U, etal. Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study. Cardiovasc Res. 2002;54(1):95-104.
42. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab. 2000;278(6):E967-E976.
43. Adams V, Jiang H, Yu J, etal. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol. 1999;33(4):959-965.
44. Vescovo G, Volterrani M, Zennaro R, etal. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart. 2000;84(4):431-437.
45. Lecker SH, Jagoe RT, Gilbert A, etal. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004;18(1):39-51.